Operating Income

Pharma

Novartis' troubled Alcon unit recalls eye drops for sterility, potency problems; Endo tanks on women's health sale;

F. Michael Ball, the former Hospira CEO who last month took over the top spot at Novartis' ($NVS) troubled Alcon unit, already had plenty on his to-do list. The division's sales are way off,...

Carly Helfand Mar 1, 2016 11:30am